Impact of dual lipid-lowering strategy with ezetimibe and atorvastatin on coronary plaque regression in patients with percutaneous coronary intervention. Insights from the multicenter randomized controlled PRECISE-IVUS trial.

Tsujita K*;Sugiyama S;Sumida H;Shimomura H;Yamashita T;Yamanaga K;Komura N;Sakamoto K;Oka H;Nakao K;Nakamura S;Ishihara M;Matsui K;Sakaino N;Nakamura N;Yamamoto N;Koide S;Matsumura T;Fujimoto K;Tsunoda R;Morikami Y;Matsuyama K;Oshima